Tori Rodriguez, MA, LPC

Researchers found that using genes as biomarkers to identify the optimal therapy might potentially someday benefit patients with rheumatoid arthritis.

The 11th edition of the International Classification of Diseases includes chronic pain in the “Symptoms, Signs or Clinical Findings” category.

Unexpected findings from the CARES trial have prompted discussion exploring the potential reasons for the observed discrepancy of increased cardiovascular mortality with febuxostat.

Racism is embedded in all US institutions, including medicine — so what steps are being taken to improve the well-being of the healthcare workforce?

Access to medications for childhood-onset systemic lupus erythematosus is currently limited, partly because of a lack of high-quality evidence from clinical trials.

Both depression and rheumatoid arthritis contribute substantially to global disability, and these diseases often co-occur.

Ongoing treatment with bisphosphonate therapy may not be needed to prevent future fractures in certain patients due to the sustained effect of the drug.

Rebecca L. Manno, MD, MHS, and Susan M. Goodman, MD, discuss renal manifestations in rheumatoid arthritis.

If dementia is driven by inflammatory processes, patients with RA would be a model population to study, as the incidence of dementia is higher in these patients and it would be expected that dementia would progress more quickly.

Although bariatric surgery is the most effective treatment strategy for severe obesity, there is a dearth of research regarding the effects of this procedure on patients with gout.

Research is still needed to explore the association between cancer chemotherapeutics and rheumatoid arthritis.

Juvenile spondyloarthritis is a distinct form of childhood arthritis because of the male predominance, later age of onset, and involvement of the entheses and axial skeleton.

Three experts share their insight on the epidemiology of swallowing disorders in rheumatoid arthritis.

Pain resulting from osteoporotic fractures should be treated with a multimodal approach that includes pharmacological and nonpharmacological strategies.

Because of the increased risk for cardiovascular disease in patients with rheumatoid arthritis, the increase in fat mass caused by rheumatoid cachexia can be especially concerning.

Rheuatology Advisor speaks with a psychologist about addressing mental health in patients with inflammatory arthritis.

Although pulmonary arterial hypertension occurs in a minority of patients with systemic sclerosis, clinicians must be attentive to it, as it can emerge at any point over the course of the disease.

Rheumatologists should coordinate with the patient’s primary care provider to facilitate an effective and comprehensive vaccination schedule.

Rheumatology Advisor speaks with Eric Matteson, MD, MPH, and Laura Cappelli, MD, MHS, regarding the risk for malignancy in patients with rheumatoid arthritis.

The available evidence suggests that radiofrequency ablation is a feasible treatment option for chronic hip pain associated with degenerative diseases.

Clinicians discuss the utility of statins in rheumatoid arthritis and further expand on CVD risk reduction in these patients.

Racial disparities have been observed in the disease course and outcomes of African Americans with SLE compared with white patients with SLE.

The EULAR definition of arthralgia suspicious for progression to RA can be used as one guideline to help identify those patients at risk for developing RA.

Infodemiology can estimate the health-related demands and behaviors of systemic lupus erythematosus.

A patient with a history of uncontrolled gout presents with highly refractile, crystal-like macular lesions.

They similarities and differences of anti-TNF drug function in RA and SpA are discussed in an expert interview.

New drugs indicated for central nervous system and gastrointestinal disorders, infection, cancer treatment, and diabetes were reviewed.

The new approach in development proposes the use of positive indirect immunofluorescence ANA (IIF-ANA) as an entry criterion for SLE classification.

Meta-analysis supports anti-RNP and anti-Sm antibodies as serological biomarkers of PAH risk in patients with systemic lupus erythematosus.

Case study of an 83-year-old male patient who developed severe hypocalcemia induced by denosumab.